Immutep selects Charles River to conduct toxicology study for IMP761

Immutep has selected Charles River Laboratories to conduct a Good Laboratory Practice (GLP) toxicology study of its proprietary preclinical candidate…

DCT Adoption Tracker reveals top therapy areas using a decentralisation approach

Telemedicine remains the leading decentralisation approach in clinical trials in Q2 of this year. The continued rise of telemedicine as…

OnQuality: developing treatments to combat cancer therapy side effects

The oncology space is one of the largest hotbeds for drug development and innovation, and in the past few decades,…


Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Vist our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.